Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zolpidem and suvorexant effects on walking adaptability in healthy elderly volunteers
NL-OMON50820Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of zolpidem and suvorexant (3 arms), sponsored by Centre for Human Drug Research. Primary endpoints: 8-meter walking test walking speed, 8-meter walking test step length and 28 more. Started Apr 2021; status: active, not recruiting.
02
Drugs
zolpidemsuvorexant
Beyond the preview
Go deeper on NL-OMON50820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50820.